BRCA1 and neoplasm: The prevalence of BRCA1/2 germline pathogenic variants varies among ethnic groups and geographical areas; however, most BRCA1/2 germline pathogenic variant patients are young (<45 years of age), have aggressive disease characteristics, and have a family history of BRCA-related tumours (3, 6).